appScorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Brooks Laboratories Ltd
BROOKS
Price Chart
Scorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.
PeersCompare with peers
Divi's Laboratories Ltd
Syngene International Ltd
Dishman Carbogen Amcis Ltd
Vimta Labs Ltd
Vaidya Sane Ayurved Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Board Meeting Intimation
BROOKS LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Download
BROOKS LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Download
Copy of Newspaper Publication
Newspaper advertisement Pursuant to Regulation 72(2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 pertaining to forthcoming Rights Issue | Download
Newspaper advertisement Pursuant to Regulation 72(2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 pertaining to forthcoming Rights Issue | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant